{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:32:57Z","timestamp":1768433577678,"version":"3.49.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Opiate use is related to neuropathological disorders, stroke and stroke attributable risk factors. However, secondary exposure to opiate in relation to the above-mentioned complications is studied only in animal models and remains to be evaluated in human populations. We tested whether passive exposure to opiate is associated with stroke and the known stroke predictive factors. We carried out a cross-sectional study of 1541 never smoker women who participated in the Rafsanjan Cohort Study (RCS) with their husbands (2015\u20132017 recruitment phase). RCS is one of the 19 geographic districts of the Prospective Epidemiological Research Studies in Iran (PERSIAN cohort study). Unadjusted and adjusted multiple logistic regression analyses were performed to evaluate the relationship between second-hand opiate exposure (husband opiate smoking after marriage) and the odds ratio of stroke and the following stroke risk factors and predictive parameters: overweight\/obesity (BMI\u2009&gt;\u200925), cholesterol (chol)\u2009&gt;\u2009200\u00a0mg\/dl, fasting blood sugar (FBS)\u2009&gt;\u2009125\u00a0mg\/dl, low density lipoprotein (LDL)\u2009&gt;\u2009100\u00a0mg\/dl, triglyceride (TG)\u2009&gt;\u2009\u2009=\u2009150\u00a0mg\/dl, hypertension, diabetes, and chronic headache. We observed a significant increased adjusted odds ratio (OR) of stroke (OR\u2009=\u20093.43, 95% CI:1.33\u20138.82) and its risk factors LDL\u2009&gt;\u2009100\u00a0mg\/dl (OR\u2009=\u20091.37, 95% CI:1.01\u20131.87) and FBS\u2009&gt;\u2009125\u00a0mg\/dl (OR\u2009=\u20091.58, 95% CI:1.08\u20132.30) in women associated with husbands\u2019 opiate smoking. This relationship was observed after adjusting for the confounding parameters including age, education years, and first-degree family history of the relevant diseases. The increased odds ratio for stroke and high LDL displayed a dose-sensitive trend with years of husband\u2019s opiate smoking after marriage (respective p-trends: 0.02 &amp; 0.01). We did not observe a significant association between passive opiate smoking and high TG, high Chol or the diseases diabetes, hypertension and chronic headache. However, 89% increased odds ratio of chronic headache was observed to be associated with passive opiate smoking for more than 10\u00a0years (OR\u2009=\u20091.89, 95% CI:1.02\u20133.50). We found an increased risk of stroke and high LDL and FBS in women associated with passive opiate smoking. Furthermore, a dose-sensitive connection was found between the risks of stroke, high LDL and chronic headache with the years of passive opiate exposure. Our results point to the necessity of the future analyses, which further assess whether passive opiate exposure could be considered as an independent risk factor for stroke and metabolic diseases.<\/jats:p>","DOI":"10.1038\/s41598-022-20861-w","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T10:02:57Z","timestamp":1664532177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cross-sectional study of passive opiate smoking in relation to stroke and some of stroke attributable risk factors in women"],"prefix":"10.1038","volume":"12","author":[{"given":"Nazanin","family":"Jalali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parvin","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Bahrampour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Mahmoudabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Esmaeili Nadimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3808-5658","authenticated-orcid":false,"given":"Zahra","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"20861_CR1","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.03.044","volume":"28","author":"SM Mousavi-Mirzaei","year":"2019","unstructured":"Mousavi-Mirzaei, S. M. et al. Increasing the risk of stroke by opium addiction. J. Stroke Cerebrovasc. Dis. 28, 1930\u20131935 (2019).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"20861_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000485098","volume":"79","author":"H Ebrahimi","year":"2018","unstructured":"Ebrahimi, H. et al. Opium addiction and ischemic stroke in Isfahan, Iran: A case-control study. Eur. Neurol. 79, 82\u201385 (2018).","journal-title":"Eur. Neurol."},{"key":"20861_CR3","first-page":"114","volume":"13","author":"F Iranmanesh","year":"2021","unstructured":"Iranmanesh, F., Syfadini, R., Mahalati, Y., Gadari, F. & Dehesh, T. Comparison of brain magnetic resonance imaging lesions in opium addict and non-addict patients with thrombotic stroke: A case-control study. Addict. Health 13, 114 (2021).","journal-title":"Addict. Health"},{"key":"20861_CR4","first-page":"76","volume":"18","author":"Y Moadabi","year":"2019","unstructured":"Moadabi, Y., Saberi, A., Hoseini, S., Karimi, A. & Yousefzadeh-Chabok, S. Cerebral hemodynamic abnormalities of patients with ischemic stroke who are opium addicted: A study by transcranial doppler ultrasonography. Iran. J. Neurol. 18, 76 (2019).","journal-title":"Iran. J. Neurol."},{"key":"20861_CR5","first-page":"131","volume":"10","author":"A Hamziee-Moghadam","year":"2018","unstructured":"Hamziee-Moghadam, A., Iranmanesh, F., Arabpour-Fathabadi, A. & Mohammadi, F. Cerebrovascular reactivity and carotid intima-media thickness in opium dependents: A case-control study. Addict. Heal. 10, 131 (2018).","journal-title":"Addict. Heal."},{"key":"20861_CR6","first-page":"95","volume":"5","author":"A Hamzei-Moghaddam","year":"2013","unstructured":"Hamzei-Moghaddam, A., Shafa, M. A., Khanjani, N. & Farahat, R. Frequency of opium addiction in patients with ischemic stroke and comparing their cerebrovascular doppler ultrasound changes to non-addicts. Addict. Health 5, 95 (2013).","journal-title":"Addict. Health"},{"key":"20861_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/00952990802122580","volume":"34","author":"L Azod","year":"2008","unstructured":"Azod, L., Rashidi, M., Afkhami-Ardekani, M., Kiani, G. & Khoshkam, F. Effect of opium addiction on diabetes. Am. J. Drug Alcohol Abuse 34, 383\u2013388 (2008).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"20861_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/13556210410001674095","volume":"9","author":"GA Karam","year":"2004","unstructured":"Karam, G. A. et al. Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus. Addict. Biol. 9, 53\u201358 (2004).","journal-title":"Addict. Biol."},{"key":"20861_CR9","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1055\/s-0031-1280017","volume":"77","author":"SK Hosseini","year":"2011","unstructured":"Hosseini, S. K. et al. Opium consumption and coronary atherosclerosis in diabetic patients: A propensity score-matched study. Planta Med. 77, 1870\u20131875 (2011).","journal-title":"Planta Med."},{"key":"20861_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.etp.2008.08.001","volume":"61","author":"A Mohammadi","year":"2009","unstructured":"Mohammadi, A. et al. Effect of opium addiction on lipid profile and atherosclerosis formation in hypercholesterolemic rabbits. Exp. Toxicol. Pathol. 61, 145\u2013149 (2009).","journal-title":"Exp. Toxicol. Pathol."},{"key":"20861_CR11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3389\/fphys.2016.00436","volume":"7","author":"H Najafipour","year":"2016","unstructured":"Najafipour, H. & Beik, A. The impact of opium consumption on blood glucose, serum lipids and blood pressure, and related mechanisms. Front. Physiol. 7, 436 (2016).","journal-title":"Front. Physiol."},{"key":"20861_CR12","first-page":"2021","volume":"31","author":"H Sanjari Moghaddam","year":"2021","unstructured":"Sanjari Moghaddam, H. et al. Cognitive impairment in opium use disorder. Behav. Neurol. 31, 2021 (2021).","journal-title":"Behav. Neurol."},{"key":"20861_CR13","doi-asserted-by":"publisher","first-page":"e197025","DOI":"10.1001\/jamanetworkopen.2019.7025","volume":"2","author":"SL Yeoh","year":"2019","unstructured":"Yeoh, S. L. et al. Cognitive and motor outcomes of children with prenatal opioid exposure: A systematic review and meta-analysis. JAMA Netw. open 2, e197025\u2013e197025 (2019).","journal-title":"JAMA Netw. open"},{"key":"20861_CR14","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/sj.npp.1300889","volume":"31","author":"KD Ersche","year":"2006","unstructured":"Ersche, K. D., Clark, L., London, M., Robbins, T. W. & Sahakian, B. J. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 31, 1036\u20131047 (2006).","journal-title":"Neuropsychopharmacology"},{"key":"20861_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-18114-3","volume":"11","author":"G Egervari","year":"2020","unstructured":"Egervari, G. et al. Chromatin accessibility mapping of the striatum identifies tyrosine kinase FYN as a therapeutic target for heroin use disorder. Nat. Commun. 11, 1\u201315 (2020).","journal-title":"Nat. Commun."},{"key":"20861_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1526-4610.1991.hed3103159.x","volume":"31","author":"M De Marinis","year":"1991","unstructured":"De Marinis, M., Janiri, L. & Agnoli, A. Headache in the use and withdrawal of opiates and other associated substances of abuse. Headache J. Head Face Pain 31, 159\u2013163 (1991).","journal-title":"Headache J. Head Face Pain"},{"key":"20861_CR17","doi-asserted-by":"crossref","first-page":"030006052092535","DOI":"10.1177\/0300060520925353","volume":"48","author":"L Li","year":"2020","unstructured":"Li, L. & Yu, S. Heroin-induced headache in female heroin addicts. J. Int. Med. Res. 48, 0300060520925353 (2020).","journal-title":"J. Int. Med. Res."},{"key":"20861_CR18","doi-asserted-by":"crossref","unstructured":"Pereska, Z., Dejanova, B., Bozinovska, C. & Petkovska, L. Prooxidative\/antioxidative homeostasis in heroin addiction and detoxification. Bratisl. Lek\u00e1rske List. Bratislava Med. J. (2007).","DOI":"10.1016\/j.toxlet.2007.05.360"},{"key":"20861_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/bs.pmbts.2015.10.001","volume":"137","author":"JS Womersley","year":"2016","unstructured":"Womersley, J. S. & Uys, J. D. S-Glutathionylation and redox protein signaling in drug addiction. Prog. Mol. Biol. Transl. Sci. 137, 87\u2013121 (2016).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"20861_CR20","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/j.1471-4159.2009.06217.x","volume":"110","author":"T Koch","year":"2009","unstructured":"Koch, T. et al. \u03bc-Opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2. J. Neurochem. 110, 1288\u20131296 (2009).","journal-title":"J. Neurochem."},{"key":"20861_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2010.06.020","volume":"113","author":"M Gutowicz","year":"2011","unstructured":"Gutowicz, M., Ka\u017amierczak, B. & Bara\u0144czyk-Ku\u017ama, A. The influence of heroin abuse on glutathione-dependent enzymes in human brain. Drug Alcohol Depend. 113, 8\u201312 (2011).","journal-title":"Drug Alcohol Depend."},{"key":"20861_CR22","doi-asserted-by":"publisher","DOI":"10.7249\/RR2733","volume-title":"Contemporary Asian Drug Policy: Insights and Opportunities for Change","author":"B Pardo","year":"2019","unstructured":"Pardo, B. Contemporary Asian Drug Policy: Insights and Opportunities for Change (RAND Corporation, 2019)."},{"key":"20861_CR23","unstructured":"Strain, E., Saxon, A. J. & Hermann, R. Opioid use disorder: Epidemiology, pharmacology, clinical manifestations, course, screening, assessment, and diagnosis. in UpToDate, Post, TW, Ed. UpToDate. Waltham, MA [cited 2018 Apr 1] (2015)."},{"key":"20861_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-88781-9","volume":"11","author":"Z Jalali","year":"2021","unstructured":"Jalali, Z., Bahrampour, S., Khalili, P., Khademalhosseini, M. & EsmaeiliNadimi, A. Cohort-based analysis of paternal opioid use in relation to offspring\u2019s BMI and plasma lipid profile. Sci. Rep. 11, 1\u201310 (2021).","journal-title":"Sci. Rep."},{"key":"20861_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jep.2009.11.011","volume":"127","author":"H Najafipour","year":"2010","unstructured":"Najafipour, H., Joukar, S., Malekpour-Afshar, R., Mirzaeipour, F. & Nasri, H. R. Passive opium smoking does not have beneficial effect on plasma lipids and cardiovascular indices in hypercholesterolemic rabbits with ischemic and non-ischemic hearts. J. Ethnopharmacol. 127, 257\u2013263 (2010).","journal-title":"J. Ethnopharmacol."},{"key":"20861_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1136\/jnnp-2018-318254","volume":"91","author":"LR \u00d8ie","year":"2020","unstructured":"\u00d8ie, L. R., Kurth, T., Gulati, S. & Dodick, D. W. Migraine and risk of stroke. J. Neurol. Neurosurg. Psychiatry 91, 593\u2013604 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"20861_CR27","first-page":"295","volume":"103","author":"FZ Caprio","year":"2019","unstructured":"Caprio, F. Z. & Sorond, F. A. Cerebrovascular disease: Primary and secondary stroke prevention. Med. Clin. 103, 295\u2013308 (2019).","journal-title":"Med. Clin."},{"key":"20861_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10654-020-00668-7","volume":"36","author":"H Hakimi","year":"2021","unstructured":"Hakimi, H. et al. The profile of Rafsanjan cohort study. Eur. J. Epidemiol. 36, 243\u2013252 (2021).","journal-title":"Eur. J. Epidemiol."},{"key":"20861_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/aje\/kwx314","volume":"187","author":"H Poustchi","year":"2018","unstructured":"Poustchi, H. et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): Rationale, objectives, and design. Am. J. Epidemiol. 187, 647\u2013655 (2018).","journal-title":"Am. J. Epidemiol."},{"key":"20861_CR30","volume-title":"Opium Poppy: Botany, Chemistry, and Pharmacology","author":"L Kapoor","year":"1995","unstructured":"Kapoor, L. Opium Poppy: Botany, Chemistry, and Pharmacology (CRC Press, 1995)."},{"key":"20861_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/MD.0000000000003922","volume":"95","author":"R Shakeri","year":"2016","unstructured":"Shakeri, R. et al. Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer. Medicine (Baltimore) 95, 28 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"20861_CR32","first-page":"691","volume":"20","author":"S Eghtesad","year":"2017","unstructured":"Eghtesad, S. et al. The PERSIAN cohort: Providing the evidence needed for healthcare reform. Arch. Iran. Med. 20, 691\u2013695 (2017).","journal-title":"Arch. Iran. Med."},{"key":"20861_CR33","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1123\/jpah.2016-0400","volume":"16","author":"N Aguilar-Farias","year":"2019","unstructured":"Aguilar-Farias, N., Brown, W. J., Skinner, T. L. & Peeters, G. G. Metabolic equivalent values of common daily activities in middle-age and older adults in free-living environments: a pilot study. J. Phys. Act. Health 16, 222\u2013229 (2019).","journal-title":"J. Phys. Act. Health"},{"key":"20861_CR34","unstructured":"Organization, W. H. Classification of Diabetes Mellitus. (2019)."},{"key":"20861_CR35","unstructured":"Organization, W. H. Global Status Report on Noncommunicable Diseases 2014. (World Health Organization, 2014)."},{"key":"20861_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/9781118548387","volume-title":"Applied Logistic Regression","author":"DW Hosmer Jr","year":"2013","unstructured":"Hosmer, D. W. Jr., Lemeshow, S. & Sturdivant, R. X. Applied Logistic Regression (Wiley, 2013)."},{"key":"20861_CR37","unstructured":"Schwender, H., Hosmer, D.W., Lemeshow, S., & May, S. Applied survival analysis: Regression modeling of time-to-event data. (2012)."},{"key":"20861_CR38","first-page":"14","volume":"2","author":"M Fisher","year":"2008","unstructured":"Fisher, M. Stroke and TIA: Epidemiology, risk factors, and the need for early intervention. Am. J. Manag. Care 2, 14 (2008).","journal-title":"Am. J. Manag. Care"},{"key":"20861_CR39","volume-title":"Clinical Epidemiology: The Essentials","author":"GS Fletcher","year":"2019","unstructured":"Fletcher, G. S. Clinical Epidemiology: The Essentials (Lippincott Williams & Wilkins, 2019)."},{"key":"20861_CR40","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/hr.2011.94","volume":"34","author":"AFG Cicero","year":"2011","unstructured":"Cicero, A. F. G. & Ertek, S. Hypertension and diabetes incidence: Confounding factors. Hypertens. Res. 34, 1069\u20131070 (2011).","journal-title":"Hypertens. Res."},{"key":"20861_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-88680-z","volume":"11","author":"M Nikparvar","year":"2021","unstructured":"Nikparvar, M. et al. Dyslipidemia and its associated factors in southern Iranian women, Bandare-Kong Cohort study, a cross-sectional survey. Sci. Rep. 11, 1\u201311 (2021).","journal-title":"Sci. Rep."},{"key":"20861_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-020-01091-9","volume":"21","author":"JL Rohmann","year":"2020","unstructured":"Rohmann, J. L., Rist, P. M., Buring, J. E. & Kurth, T. Migraine, headache, and mortality in women: A cohort study. J. Headache Pain 21, 1\u20138 (2020).","journal-title":"J. Headache Pain"},{"key":"20861_CR43","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/jp.2012.124","volume":"33","author":"R Chavez-Valdez","year":"2013","unstructured":"Chavez-Valdez, R. et al. Opioids and clonidine modulate cytokine production and opioid receptor expression in neonatal immune cells. J. Perinatol. 33, 374\u2013382 (2013).","journal-title":"J. Perinatol."},{"key":"20861_CR44","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/00000542-200703000-00018","volume":"106","author":"C-F Lam","year":"2007","unstructured":"Lam, C.-F. et al. High-dose morphine impairs vascular endothelial function by increased production of superoxide anions. J. Am. Soc. Anesthesiol. 106, 532\u2013537 (2007).","journal-title":"J. Am. Soc. Anesthesiol."},{"key":"20861_CR45","first-page":"1449","volume":"7","author":"S Samarghandian","year":"2014","unstructured":"Samarghandian, S., Afshari, R. & Farkhondeh, T. Effect of long-term treatment of morphine on enzymes, oxidative stress indices and antioxidant status in male rat liver. Int. J. Clin. Exp. Med. 7, 1449 (2014).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"20861_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.imlet.2013.07.001","volume":"153","author":"A Ghazavi","year":"2013","unstructured":"Ghazavi, A., Mosayebi, G., Solhi, H., Rafiei, M. & Moazzeni, S. M. Serum markers of inflammation and oxidative stress in chronic opium (Taryak) smokers. Immunol. Lett. 153, 22\u201326 (2013).","journal-title":"Immunol. Lett."},{"key":"20861_CR47","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/ADM.0b013e31828baede","volume":"7","author":"A Ghazavi","year":"2013","unstructured":"Ghazavi, A., Solhi, H., Moazzeni, S. M., Rafiei, M. & Mosayebi, G. Cytokine profiles in long-term smokers of opium (Taryak). J. Addict. Med. 7, 200\u2013203 (2013).","journal-title":"J. Addict. Med."},{"key":"20861_CR48","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fped.2020.00272","volume":"8","author":"J Newville","year":"2020","unstructured":"Newville, J., Maxwell, J. R., Kitase, Y., Robinson, S. & Jantzie, L. L. Perinatal opioid exposure primes the peripheral immune system toward hyperreactivity. Front. Pediatr. 8, 272 (2020).","journal-title":"Front. Pediatr."},{"key":"20861_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.imlet.2013.04.003","volume":"152","author":"S Nabati","year":"2013","unstructured":"Nabati, S. et al. The plasma levels of the cytokines in opium-addicts and the effects of opium on the cytokines secretion by their lymphocytes. Immunol. Lett. 152, 42\u201346 (2013).","journal-title":"Immunol. Lett."},{"key":"20861_CR50","first-page":"149","volume":"7","author":"M Masoomi","year":"2015","unstructured":"Masoomi, M., Azdaki, N. & Shahouzehi, B. Elevated plasma homocysteine concentration in opium-addicted individuals. Addict. Health 7, 149 (2015).","journal-title":"Addict. Health"},{"key":"20861_CR51","first-page":"916","volume":"12","author":"B Shahouzehi","year":"2013","unstructured":"Shahouzehi, B., Shokoohi, M. & Najafipour, H. The effect of opium addiction on serum adiponectin and leptin levels in male subjects: A case control study from kerman coronary artery disease risk factors study (KERCADRS). EXCLI J. 12, 916 (2013).","journal-title":"EXCLI J."},{"key":"20861_CR52","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3390\/biomedicines9111602","volume":"9","author":"E Hasheminasabgorji","year":"2021","unstructured":"Hasheminasabgorji, E. & Jha, J. C. Dyslipidemia, diabetes and atherosclerosis: Role of inflammation and ROS-redox-sensitive factors. Biomedicines 9, 1602 (2021).","journal-title":"Biomedicines"},{"key":"20861_CR53","doi-asserted-by":"publisher","first-page":"7432","DOI":"10.3390\/ijms22147432","volume":"22","author":"T Behl","year":"2021","unstructured":"Behl, T. et al. Current trends in neurodegeneration: Cross talks between oxidative stress, cell death, and inflammation. Int. J. Mol. Sci. 22, 7432 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"20861_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052354","volume":"7","author":"K-H Chan","year":"2012","unstructured":"Chan, K.-H. et al. Adiponectin is protective against oxidative stress induced cytotoxicity in amyloid-beta neurotoxicity. PLoS ONE 7, e52354 (2012).","journal-title":"PLoS ONE"},{"key":"20861_CR55","first-page":"1817","volume":"41","author":"J Guo","year":"2018","unstructured":"Guo, J., Zhao, X., Li, Y., Li, G. & Liu, X. Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease. Int. J. Mol. Med. 41, 1817\u20131825 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"20861_CR56","doi-asserted-by":"crossref","unstructured":"Gazaryan, I. G. & Ratan, R. R. Oxidative damage in neurodegeneration and injury. (2017).","DOI":"10.1016\/B978-0-12-809324-5.02006-X"},{"key":"20861_CR57","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.2174\/0929867321666131227161303","volume":"21","author":"G Aliev","year":"2014","unstructured":"Aliev, G. et al. Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease. Curr. Med. Chem. 21, 2208\u20132217 (2014).","journal-title":"Curr. Med. Chem."},{"key":"20861_CR58","doi-asserted-by":"publisher","first-page":"e3102","DOI":"10.1038\/cddis.2017.491","volume":"8","author":"J Song","year":"2017","unstructured":"Song, J., Choi, S.-M., Whitcomb, D. J. & Kim, B. C. Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity. Cell Death Dis. 8, e3102\u2013e3102 (2017).","journal-title":"Cell Death Dis."},{"key":"20861_CR59","first-page":"4","volume":"6","author":"M-H Wu","year":"2019","unstructured":"Wu, M.-H. Adiponectin: A pivotal role in the protection against cerebral ischemic injury. Neuroimmunol. Neuroinflamm. 6, 4 (2019).","journal-title":"Neuroimmunol. Neuroinflamm."},{"key":"20861_CR60","first-page":"9601","volume":"24","author":"XX Wang","year":"2020","unstructured":"Wang, X. X., Zhang, B., Xia, R. & Jia, Q. Y. Inflammation, apoptosis and autophagy as critical players in vascular dementia. Eur. Rev. Med. Pharmacol. Sci. 24, 9601\u20139614 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"20861_CR61","doi-asserted-by":"crossref","unstructured":"Khajedaluee, M., Rezaee, S. A., Valizadeh, N., Hassannia, T. & Paykani, T. Concordance assessment between self-reports of substance use and urinalysis: A population-based study in Mashhad, Iran. J. Ethn. Subst. Abuse 1\u201315 (2020).","DOI":"10.1080\/15332640.2020.1785362"},{"key":"20861_CR62","doi-asserted-by":"publisher","first-page":"183017","DOI":"10.1371\/journal.pone.0183017","volume":"12","author":"H Rashidian","year":"2017","unstructured":"Rashidian, H. et al. Sensitivity of self-reported opioid use in case-control studies: Healthy individuals versus hospitalized patients. PLoS ONE 12, 183017 (2017).","journal-title":"PLoS ONE"},{"key":"20861_CR63","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1158\/1055-9965.1068.13.6","volume":"13","author":"CC Abnet","year":"2004","unstructured":"Abnet, C. C. et al. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol. Prev. Biomark. 13, 1068\u20131070 (2004).","journal-title":"Cancer Epidemiol. Prev. Biomark."},{"key":"20861_CR64","doi-asserted-by":"publisher","first-page":"225","DOI":"10.15171\/hpp.2018.30","volume":"8","author":"S Ashrafi","year":"2018","unstructured":"Ashrafi, S. et al. The validity of self-reported drug use with urine test: Results from the pilot phase of Azar cohort study. Heal. Promot. Perspect. 8, 225 (2018).","journal-title":"Heal. Promot. Perspect."},{"key":"20861_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-020-00336-9","volume":"16","author":"P Khalili","year":"2021","unstructured":"Khalili, P. et al. Validity of self-reported substance use: Research setting versus primary health care setting. Subst. Abuse Treat. Prevent. Policy 16, 1\u201313 (2021).","journal-title":"Subst. Abuse Treat. Prevent. Policy"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20861-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20861-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20861-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T10:08:07Z","timestamp":1664532487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20861-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20861"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20861-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"30 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16367"}}